Our Team
Success depends on the right combination of expertise and experience. Our project teams are hand-picked to meet your needs.

John Pinney
Founder and CEO

Joe Gitchell
President

Lucy Owen
Senior Vice President

Judy Ashworth, MD
Vice President, Rx Strategic Services and Chief Medical Officer

Jack Henningfield, PhD
Vice President, Research, Health Policy, and Abuse Liability

Saul Shiffman, PhD
Senior Scientific Advisor, Behavioral Science, Study Design, and Analysis

Bernie Simone
Vice President, Client Strategy and Rx-to-OTC Switch

George Quesnelle
Senior Strategic Advisor, OTC Commercialization and Optimization

Sidney Schnoll, MD, PhD
Vice President, Pharmaceutical Risk Management

August Buchhalter, PhD, MA
Director, Abuse Potential Assessment

Marion Coe, PhD
Director, Clinical Development and Postmarketing Surveillance

Robyn Gougelet
Director, Health Policy and Regulatory Strategy

Ryan Lanier, PhD
Director, Clinical Development and Abuse Liability

Mark Sembower, MS
Director, Data Management and Statistical Analysis

Christine Sweeney, PhD, MPH
Director, Issues Management

Daniel Wang
Director, Cannabinoids and New Dietary Ingredients

Lisa Zapawa, MD, MPH
Director, Medical Science

Michelle Ertischek, MPH
Director, Planning and Operations

Steve Choi
Director of Finance

Arielle Selya, PhD
Scientist

Sooyong Kim, MD, MPH
Scientist

Sarah Scholl, MPH
Senior Associate

Gina Bittner
Senior Associate

Rachel Beck, PhD
Scientist

Michael Hannon, MA
Data Analyst

Steve Pype
Senior Data Manager

Erin Nealer
Associate

Floe Foxon
Data Analyst

Caitlyn Grubb
Junior Associate

Gabrielle Blythe
Meeting Coordinator and Executive Assistant
Marilyn Huestis, PhD
Science and Policy Advisor, Clinical Pharmacology and Toxicology, Cannabinoid and Other CNS-Active Pharmacotherapies
Tom Huijbers, MS
Advisor, Regulatory Affairs
Janet Iles, MD, MPH
Advisor, Clinical Development & Drug Safety
Karen Sees, DO
Senior Scientific Advisor, Drug Development and Pharmacovigilance

Speak to an expert.
Contact Us